OptiNose Competitors and Similar CompaniesClear all
OptiNose's competitors and similar companies include Veloxis Pharmaceuticals and Avedro.
 Veloxis Pharmaceuticals Veloxis Pharmaceuticals is a biopharmaceutical company that identifies, develops, and commercializes products used in transplantation and adjacent therapies. |  Avedro Avedro is a medical device and pharmaceutical company that produces and delivers drugs and devices for corneal remodeling to eye care professionals. | ||
Founding Date | Founding Date 2000 | Founding Date 2002 | Founding Date 2002 |
Type | Type Public | Type Subsidiary | Type Subsidiary |
Tags | |||
Locations | Locations Morrisville, US HQ Oslo, NO Swindon, GB | Locations København, DK HQ Cary, US Cary, US | Locations Waltham, US HQ |
Employees | Employees 2048% decrease | Employees 54 | Employees 122 |
Financial | |||
Revenue (est.) | Revenue (est.) $78.2m (FY, 2024) | Revenue (est.) kr39.5m (FY, 2018) | Revenue (est.) $27.7m (FY, 2018) |
Cost of goods | Cost of goods $7.2m (FY, 2024) | Cost of goods kr7.9m (FY, 2018) | Cost of goods $10.9m (FY, 2018) |
Gross profit | Gross profit $71m (FY, 2024) | Gross profit kr31.6m (FY, 2018) | Gross profit $16.8m (FY, 2018) |
Net income | Net income ($21.5m) (FY, 2024) | Net income (kr5.3m) (FY, 2018) | Net income ($25.1m) (FY, 2018) |
Operating ⚠ | |||
Patents (US) | Patents (US) 43 (Jun, 2017) | Patents (US) N/A | Patents (US) 15 (Mar, 2019) |
Trademarks (US) | Trademarks (US) 3 (Jun, 2017) | Trademarks (US) N/A | Trademarks (US) 10 (Mar, 2019) |
Funding | |||
Total funding raised | Total funding raised $ 120.5m | Total funding raised $ 60m | Total funding raised $ 67.6m |
For sources of this data, please see the company profile
View Company Profiles
Veloxis Pharmaceuticals
HQ
København, DK
Veloxis Pharmaceuticals is a biopharmaceutical company that identifies, develops, and commercializes products used in transplantation and adjacent therapies.
View companyAvedro
HQ
Waltham, US
Avedro is a medical device and pharmaceutical company that produces and delivers drugs and devices for corneal remodeling to eye care professionals.
View company